Voeller B, Coulson AH, Bernstein GS, et al. Mineral oil lubricant causes rapid deterioration of latex condoms. Contraception 1989;39:95–102.
28.
Stone KM, Grimes DA, Magder LS. Personal protection against sexually transmitted diseases. Am J Obstet Gynecol 1986;155:180– 188.
29.
Kelaghan J, Rubin GL, Ory HW, et al. Barrier-method contraceptives and pelvic inﬂammatory disease. JAMA 1982;248:184–187.
30.
Cramer DW, Goldman MB, Schiff I, et al. The relationship of tubal infertility to barrier method and oral contraceptive use. JAMA 1987;257:2246–2250.
31.
Judson FN, Ehret JM, Bodin GF, et al. In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barrier against Chlamydia trachomatis, herpes simplex virus type 2 and human immunodeficiency virus. Sex Transm Dis 1989;16: 251–256.
32.
Fischl MA, Dickinson GM, Scott GB, et al. Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. JAMA 1987;257:640–644.
33.
deVincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994;331:341– 346.
34.
Hira SK, Feldblum PJ, Kamanga J, et al. Condom and nonoxynol9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int J STI AIDS 1997;8:243–250.
35.
Wilkinson D, Ramjee G, Tholandi M, et al. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database Syst Rev 2002;4:CD003939.
36.
Harris RW, Brinton LA, Cowdell RH, et al. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer 1980;42:359–369.
37.
Parazzini F, Negri E, La Vecchia C, et al. Barrier methods of contraception and the risk of cervical neoplasia. Contraception 1989;40: 519–530.
38.
Rowlands S. New technologies in contraception. BJOG 2009;116: 230–239.
39.
Valappil T, Kelaghan J, Macaluso M, et al. Female condom and male condom failure among women at high risk for sexually transmitted disease. Sex Transm Dis 2005;32:35–43.
40.
Galvao LW, Oliveira LC, Diaz J, et al. Effectiveness of female condom and male condom in preventing exposure to semen during vaginal intercourse: a randomized trial. Contraception 2005;71:130– 136.
41.
Trussel J, Sturgen K, Strickler J, et al. Comparative efficacy of the female condom and other barrier methods. Fam Plann Perspect 1994;26:66–72.
42.